An analysis found that MS patients on a less frequent anti-CD20 therapy dosing schedule do not have more relapses or show ...

An international research team has secured nearly $800,000 to advance a potential regenerative therapy for MS toward clinical ...

Drs Anne Cross and Scott Newsome discuss new horizons in MS treatment strategies, including the TREAT-MS trial and shared decision-making for optimal patient care.

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

Research highlights a strong link between Epstein-Barr virus and multiple sclerosis (MS), suggesting new therapeutic ...

A Canadian-led international research team, spearheaded by Dr. Fang Liu at the Centre for Addiction and Mental Health (CAMH) ...

Dr Devon Conway describes how the upcoming conference is expected to provide important new data on the safety and real-world ...

In gene therapy, a gene (a piece of DNA) is introduced into cells. This process uses a virus that has been stripped of its disease-causing properties—referred to as a viral vector—as the delivery ...

Multiple sclerosis (MS) is a debilitating autoimmune disease of the brain and spinal cord. The disease can affect everyone differently, but depending on the progression and severity of the disease, ...

Cognitive behavioral therapy and the mild stimulant modafinil both reduce fatigue in people with multiple sclerosis by about the same amount, finds a new study. Combining talk therapy and medication ...

There has always been one gesture that he was unwilling to sacrifice, however, and that was getting on one knee to propose.